HIND
NASDAQ · Pharmaceuticals
Vyome Holdings Inc
$2.12
-0.05 (-2.30%)
Open$2.20
Previous Close$2.17
Day High$2.35
Day Low$2.10
52W High$18.60
52W Low$1.75
Volume—
Avg Volume20.5K
Market Cap15.23M
P/E Ratio—
EPS$-12.41
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+801.9% upside
Current
$2.12
$2.12
Target
$19.12
$19.12
$13.94
$19.12 avg
$23.15
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.04M | 3.40M | 5.84M |
| Net Income | -33,323,971 | -98,236,403 | 1.21M |
| Profit Margin | -3,209.8% | -3,049.3% | 20.8% |
| EBITDA | -33,903,701 | -105,497,923 | 1.81M |
| Free Cash Flow | — | — | 575.3K |
| Rev Growth | -69.5% | -69.5% | -9.0% |
| Debt/Equity | — | — | 0.79 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |